SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 230 filers reported holding SAGE THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 0.96 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $11,639,389 | -18.7% | 565,568 | +85.8% | 0.00% | 0.0% |
Q2 2023 | $14,309,409 | +236.2% | 304,326 | +200.1% | 0.00% | +100.0% |
Q1 2023 | $4,255,751 | -26.3% | 101,424 | -33.0% | 0.00% | 0.0% |
Q4 2022 | $5,776,875 | -45.1% | 151,465 | -43.6% | 0.00% | -50.0% |
Q3 2022 | $10,523,000 | +116.9% | 268,696 | +78.9% | 0.00% | – |
Q2 2022 | $4,851,000 | -47.3% | 150,190 | -46.0% | 0.00% | -100.0% |
Q1 2022 | $9,206,000 | -83.2% | 278,146 | -78.4% | 0.00% | -75.0% |
Q4 2021 | $54,835,000 | +31.4% | 1,289,045 | +36.9% | 0.01% | +50.0% |
Q3 2021 | $41,727,000 | -34.9% | 941,690 | -16.6% | 0.01% | -42.9% |
Q2 2021 | $64,117,000 | +211.1% | 1,128,610 | +309.9% | 0.01% | +133.3% |
Q1 2021 | $20,608,000 | -64.2% | 275,319 | -58.6% | 0.01% | -60.0% |
Q4 2020 | $57,489,000 | -42.0% | 664,544 | -59.1% | 0.02% | -46.4% |
Q3 2020 | $99,189,000 | +25.4% | 1,622,863 | -14.7% | 0.03% | 0.0% |
Q2 2020 | $79,069,000 | +269.0% | 1,901,613 | +154.9% | 0.03% | +180.0% |
Q1 2020 | $21,428,000 | -67.0% | 746,107 | -17.1% | 0.01% | -65.5% |
Q4 2019 | $64,988,000 | +20.2% | 900,222 | +133.6% | 0.03% | +11.5% |
Q3 2019 | $54,053,000 | +26.3% | 385,297 | +64.9% | 0.03% | +36.8% |
Q2 2019 | $42,792,000 | +98.9% | 233,723 | +72.8% | 0.02% | +90.0% |
Q1 2019 | $21,518,000 | -13.1% | 135,287 | -47.6% | 0.01% | -28.6% |
Q4 2018 | $24,754,000 | -40.0% | 258,417 | -11.6% | 0.01% | -22.2% |
Q3 2018 | $41,291,000 | +148.0% | 292,322 | +174.8% | 0.02% | +125.0% |
Q2 2018 | $16,649,000 | -17.4% | 106,361 | -15.0% | 0.01% | -27.3% |
Q1 2018 | $20,156,000 | -12.8% | 125,146 | -10.8% | 0.01% | -26.7% |
Q4 2017 | $23,117,000 | +108.0% | 140,351 | -21.3% | 0.02% | +66.7% |
Q3 2017 | $11,114,000 | +75.3% | 178,400 | +124.1% | 0.01% | +80.0% |
Q2 2017 | $6,341,000 | -43.9% | 79,611 | -49.9% | 0.01% | -54.5% |
Q1 2017 | $11,302,000 | +102.9% | 159,032 | +45.8% | 0.01% | +83.3% |
Q4 2016 | $5,569,000 | -90.8% | 109,060 | -91.7% | 0.01% | -90.2% |
Q3 2016 | $60,312,000 | +207.9% | 1,309,713 | +101.5% | 0.06% | +177.3% |
Q2 2016 | $19,585,000 | +25.8% | 650,008 | +33.9% | 0.02% | +10.0% |
Q1 2016 | $15,565,000 | +11.4% | 485,511 | +102.6% | 0.02% | +33.3% |
Q4 2015 | $13,973,000 | +158.9% | 239,673 | +87.9% | 0.02% | +200.0% |
Q3 2015 | $5,398,000 | +722.9% | 127,546 | +877.1% | 0.01% | +400.0% |
Q1 2015 | $656,000 | -67.1% | 13,054 | -76.0% | 0.00% | -50.0% |
Q4 2014 | $1,993,000 | +54.1% | 54,462 | +32.7% | 0.00% | +100.0% |
Q3 2014 | $1,293,000 | – | 41,037 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |